Antenatal therapy with corticosteroids and postpartum complications.
In a group of patients receiving dexamethasone antenataly, there was no difference in incidence of postpartum complications when compared to a group treated with a placebo. It is concluded that, from the maternal point of view, selected pregnant patients may safely receive corticosteroids to minimize the incidence of respiratory distress syndrome.
D003907:Dexamethasone / Q000627:therapeutic use*; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000453:epidemiology; D006801:Humans; D006973:Hypertension / Q000453:epidemiology; D007231:Infant, Newborn; D007239:Infections / Q000453:epidemiology; D011247:Pregnancy; D011644:Puerperal Disorders / Q000453:epidemiology*; D012127:Respiratory Distress Syndrome, Newborn / Q000517:prevention & control
D003907:Dexamethasone